$CBT

American Century entities (CBT) disclose over 5% ownership in Cabot Corporation

American Century ETF Trust and affiliated entities filed a Schedule 13G for Cabot Corporation common stock. American Century ETF Trust reported 2,640,178 shares, 5.1% of the class, with sole voting and dispositive power. American Century Investment Management, American Century Companies, and Stowers Institute reported 2,768,176 shares, 5.4%, also with sole power. No single advised client owns more than 5%.

Original reporting
Published Aug 14, 2026, 6:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CBT
Neutral
medium confidence
Mentioned
$CBT
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBTNeutralLow
01

Why it matters

The key new information is the reported beneficial ownership level (5.1% and 5.4%) with sole voting and dispositive power for the reporting persons.

02

Market read

Ownership disclosures can influence positioning and monitoring, but this text contains no fundamental catalyst for Cabot.

03

What to watch

Traders may overreact to the 5% headline; the filing also states no single advised client exceeds 5%, which can reduce the likelihood of concentrated control behavior.

Relevance 4/10Novelty 6/10Timing: today’s SEC Schedule 13G disclosure (dated 06/30/2026)

Background

The article summarizes an SEC Schedule 13G beneficial ownership filing by American Century entities for Cabot Corporation common stock.

Company-level read

Ticker impact

$CBTNeutralMedium confidence
Context

American Century ETF Trust and affiliates disclosed beneficial ownership of Cabot Corporation common stock at 5.1% and 5.4% via SEC Schedule 13G.

Expected impact

Likely limited near-term price impact, but it can modestly shift sentiment and increase attention from other investors.

Evidence & confidence

The filing provides a fresh, concrete ownership datapoint (5.1% and 5.4%) but no accompanying operational, financial, or control change beyond beneficial ownership reporting.

Market effects

No direct sector read-through; this is company-specific ownership disclosure.

None indicated.

None indicated.

Counterpoint

A 13G above 5% does not necessarily imply activism or near-term strategic change, so the market may discount it.

Key entities

  • Cabot Corporation

    Subject of the Schedule 13G beneficial ownership disclosure.

  • American Century ETF Trust

    Reported 2,640,178 shares, 5.1% of the class, with sole voting and dispositive power.

  • American Century Investment Management, Inc.

    Reported 2,768,176 shares, 5.4% of the class, with sole voting and dispositive power.

  • American Century Companies, Inc.

    Also reported 2,768,176 shares, 5.4% of the class, with sole voting and dispositive power.

  • Stowers Institute for Medical Research

    Identified in the filing as part of the beneficial ownership group holding 2,768,176 shares, 5.4%.

Related articles

$CBTMed

Cabot Details Interim CFO Appointment as CEO Succession Nears

Cabot Corporation (NYSE: CBT) appointed Steve Delahunt as interim CFO effective 1 October 2026. This follows CEO Sean Keohane's retirement and CFO Erica McLaughlin's promotion to president and CEO. The company reported a significant drop in Q3 2026 net income to $6M from $101M year-over-year, while revenue rose to $982M from $923M. CBT shares were at $80.73 as of 15 September, up 3.18% in 24 hours but down 3.39% over 20 days.

$CBTMedAI 8/10

What Cabot (CBT)'s New 2029 Debt Issuance and 2026 Note Redemption Means For Shareholders

Cabot Corporation (CBT) issued $350M in 4.950% senior notes due 2029, using proceeds to redeem $250M in 3.40% notes maturing in September 2026 and for working capital. The company projects $4B revenue and $479.7M earnings by 2029, requiring 3.5% yearly revenue growth. Analysts' views vary on earnings potential, with some estimating $499M by 2029. The refinancing aims to improve financial flexibility but does not alter near-term business challenges, including margin stabilization and Reinforcemen

$CBTMedAI 8/10

Cabot’s New US$350 Million Bond Issue Might Change The Case For Investing In CBT

Cabot Corporation issued US$350 million in senior unsecured notes due 2029, altering its funding mix. The move may impact investor views on balance sheet flexibility, especially as earnings have softened. Q3 2026 results showed US$6 million net income on US$982 million sales, with full-year EPS guidance of US$2.77. The company projects US$4.0 billion revenue and US$479.7 million earnings by 2029.